Twitter | Search | |
New York Stem Cell Foundation Research Institute 22 Jun 18
Robert Deans of ⁦⁩ kicks off our sponsored Road to the Clinic session: “The question in translating stem cell research to the clinic has always been: are we there yet? I think we finally are.”
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
An inspirational story to start the session by of & , 2011 NYSCF Stem Cell Prize winner, about his 15-year journey to restore eyesight –culminating in a successful cellular therapy for age-related macular degeneration
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @Kaufm020 @UCSanDiego
Next up: Dan Kaufman of on using human to produce natural killer cells for cancer
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @Kaufm020
.: why use NK cells for ? Unlike T cells, they kill targets (including tumors and viral-infected cells) without HLA restriction & function as allogeneic cells (do not need to be patient-matched) - many clinical trials underway
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @Kaufm020
. anticipates a clinical trial this year to test -derived NK cells as a ‘standardized, off-the-shelf’ and hopefully safer cancer
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @NIH @NatEyeInstitute
Kapil Bharti of presenting innovative approaches to engineer 3D eye tissue from iPSCs that can be used to replace complex structures in advanced stages of blinding eye diseases
Reply Retweet Like
New York Stem Cell Foundation Research Institute
Miki Ando of Juntendo University describing development of an -derived cytotoxic T lymphocyte therapy for EBV-associated , preparing for clinical trial
Reply Retweet Like More
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @panCELLaInc
Safety concerns are a key factor limiting the implementation of cell-based therapies. Claudio Monetti of describes FailSafe system for generating cells safe for clinical use, in collaboration with Nagy lab @SinaiHealthTO
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @ChildrensLA
Fixing the 'second brain': Tracy Grikscheit of on using hPSCs to restore function of the intestine's nervous system in pediatric disorders
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @nyscf
Grikscheit: engineering small intestine tissue from ES-derived human intestinal organoids
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @studerl @nature
Engineering the enteric nervous system via for and : collaboration between Tracy Grikscheit and published in :
Reply Retweet Like
New York Stem Cell Foundation Research Institute 22 Jun 18
Replying to @ChildrensLA
Grikscheit's impressive progress in restoring enteric nervous system function via implantation of -derived neural crest cells
Reply Retweet Like
BiotechMania 23 Jun 18
Replying to @nyscf
ISSR2018で安藤先生が発表した Road to the Clinic というセッションはニューヨーク幹細胞基金がスポンサーでしたので早速アップされていますね。 Preparing for clinical trial 臨床試験を準備中とのことです。
Reply Retweet Like